ClinicalTrials.gg
Sign In

Cholangitis clinical trials

The registry lists 82 studies for Cholangitis across more than 10 countries. 17 are recruiting or about to start. 34 of them are mainly about Cholangitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its narrower condition Cholangitis, Sclerosing too: 225 studies, 55 open.

Get an email when these change. Save the Cholangitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
38
Status unknown
13
Recruiting
11
Terminated
8
Not yet recruiting
6
Active, not recruiting
4

Phase

Phase 2
11
Phase 4
6
Phase 1
1
Phase 3
1

Where

China
17
United States
10
Korea, Republic of
7
France
6
Egypt
6
Germany
5

Who runs them

Hepatopancreatobiliary Surgery Institute of Gansu Province (4) · Seoul National University Hospital (3) · Asian Institute of Gastroenterology, India (3) · Assiut University (2) · Xiaoli Fan (2) · Bayer (2) · University Hospital, Geneva (2) · Assistance Publique - Hôpitaux de Paris (2)

What is being tested here

Drugs under test in Cholangitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ketamine102
Upadacitinib101
Remifentanil101
Ceftriaxone003
Berberine ursodeoxycholate002
Volixibat001
Sulfasalazine001
Teicoplanin001
Moxifloxacin001
Lacticaseibacillus rhamnosus 35001

Coming up

0phase 3 studies under way
8studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 8

Who these studies take

Of the 11 Cholangitis studies recruiting now, 6 (55%) set no upper age limit and 1 (9%) stop at 75 or younger. 2 (18%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 11
AgeWomenMen
101 (9%)1 (9%)
1810 (91%)10 (91%)
3010 (91%)10 (91%)
4010 (91%)10 (91%)
5010 (91%)10 (91%)
6510 (91%)10 (91%)
7510 (91%)10 (91%)
859 (82%)9 (82%)

Across all 82 studies, recruiting or not: 24% stop at 75 or younger and 15% at 65; 24% take children; 1% are for women only and 0% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Cholangitis studies take

Of 21 interventional studies with no phase under Cholangitis, half reached primary completion within 43 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase43 mo32–68 · 21 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 82. Browse all 82 → or search them.